Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
47582-2 Biopterin/Creatinine SRto Urine Pt Qn     ACTIVE Biopterin/Creatinine [Molar ratio] in Urine   MIN DefinitionDescription     umol/mmol creatinine             CHEM   47582-2         Both       0 Biopterin/Creat Ur-sRto       N   BIOPT; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn 2.7 2.21               umol/mmol{creat}       0
47583-0 C peptide^1.5H post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47583-0         Both       0 C peptide 1.5h p Glc SerPl-sCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p Glc; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47584-8 C peptide^10M post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --10 minutes post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47584-8         Both       0 C peptide 10M p Glc SerPl-sCnc       N   10M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47585-5 C peptide^15M post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --15 minutes post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47585-5         Both       0 C peptide 15M p Glc SerPl-sCnc       N   15M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47586-3 C peptide^1H post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --1 hour post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47586-3         Both       0 C peptide 1h p Glc SerPl-sCnc       N   1 hour; 1.0Hr; 1h p Glc; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47587-1 C peptide^1M post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --1 minute post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47587-1         Both       0 C peptide 1M p Glc SerPl-sCnc       N   1M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47588-9 C peptide^2H post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --2 hours post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47588-9         Both       0 C peptide 2h p Glc SerPl-sCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47589-7 C peptide^30M post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --30 minutes post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47589-7         Both       0 C peptide 30M p Glc SerPl-sCnc       N   30M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
4759-7 HLA-B52(5) PrThr Bld/Tiss Pt Ord     ACTIVE HLA-B52(5) [Presence]   MIN DefinitionDescription                   HLA   4759-7         Observation       0 HLA-B52(5) Ql           Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-B w52(5); Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.56 1                     This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
47590-5 C peptide^3H post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --3 hours post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47590-5         Both       0 C peptide 3h p Glc SerPl-sCnc       N   3h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47591-3 C peptide^3M post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --3 minutes post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47591-3         Both       0 C peptide 3M p Glc SerPl-sCnc       N   3M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47592-1 C peptide^5M post dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --5 minutes post dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47592-1         Both       0 C peptide 5M p Glc SerPl-sCnc       N   5M p dose; 5M p Glc; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p dose; p Glc; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47593-9 C peptide^5M pre dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --5 minutes pre dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47593-9         Both       0 C peptide 5M pre Glc SerPl-sCnc       N   5M pre Glc; Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Pept; Pl; Plasma; Plsm; Point in time; pre Glc; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47594-7 C peptide^pre dose glucagon SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --pre dose glucagon   MIN DefinitionDescription     nmol/L             CHAL   47594-7         Both       0 C peptide pre Gc SerPl-sCnc       N   Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; HGF; Hyperglycemic factor; Level; Pept; Pl; Plasma; Plsm; Point in time; pre Gc; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47595-4 C peptide^pre dose glucose SCnc Ser/Plas Pt Qn     ACTIVE C peptide [Moles/volume] in Serum or Plasma --pre dose glucose   MIN DefinitionDescription     nmol/L             CHAL   47595-4         Both       0 C peptide pre Glc SerPl-sCnc       N   Before; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Pept; Pl; Plasma; Plsm; Point in time; pre Glc; Pro-insulin c peptide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               nmol/L       0
47596-2 Calcium.ionized SCnc Bld Pt Qn ISE   ACTIVE Calcium.ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE)   MIN DefinitionDescription     mmol/L             CHEM   47596-2   ISE     Both       0 Ca-I Bld ISE-sCnc       N   Blood; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Ion selective membrane electode; Ion selective membrane electrode; Ion-selective electrode; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood 2.73 2.21               mmol/L       0
47597-0 Calcium^^corrected for total protein SCnc Bld Pt Qn     ACTIVE Calcium [Moles/volume] corrected for total protein in Blood   MIN DefinitionDescription     mmol/L             CHEM   47597-0         Both       0 Calcium TP cor Bld-sCnc       N   Blood; Ca; Cal; Chemistry; Level; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tot; Totl; TP cor; WB; Whole blood 2.7 2.21               mmol/L       0
47598-8 Calcium.ionized^^adjusted to pH 7.4 SCnc Bld Pt Qn     ACTIVE Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood   MIN DefinitionDescription     mmol/L             CHEM   47598-8         Both       0 Ca-I adj pH7.4 Bld-sCnc       N   adj; adj pH7.4; Blood; Ca; Ca-I; Cal; Calcium active; Calcium free; Chemistry; Coagulation factor I; ICA; Ion; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood 2.73 2.21               mmol/L       0
47599-6 Carbon dioxide^^adjusted to patient's actual temperature PPres BldCo Pt Qn     ACTIVE Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Cord blood   MIN DefinitionDescription     mm Hg             CHEM   47599-6         Both       0 pCO2 temp adj BldCo       N   adj; Blood - (umbilical) cord; Carbonic anhydride; Chemistry; CO2; Cord (umbilical) blood; Cord bld; Cord blood; Gyn; Gynecology; OB; ObGyn; Obstetrics; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Temp; temp adj 2.7 2.21               mm[Hg]     Changed component from 'patients' to correct typographical error. 0
476-2 Sulfonamide Susc Isolate Pt OrdQn MIC   ACTIVE Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   476-2   MIC     Observation       0 Sulfonamide Islt MIC           ANTIBIOTIC SUSCEPTIBILITIES; AST; C75; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sulf; Sulfa; Sulfas; Sulfonamides; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1                       0
4760-5 HLA-B53 PrThr Bld/Tiss^Donor Pt Ord     ACTIVE HLA-B53 [Presence] in Donor   MAJ DefinitionDescription                   HLA   4760-5         Observation       0 HLA-B53 Donr Ql           Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.56 1                     This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
47600-2 Ceruloplasmin SCnc Ser/Plas Pt Qn     ACTIVE Ceruloplasmin [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             CHEM   47600-2         Both       0 Ceruloplasmin SerPl-sCnc       N   Caeruloplasmin; Chemistry; Copper oxidase; Cp; Ferroxidase; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.21               umol/L       0
47601-0 Choriogonadotropin.beta subunit.free ACnc Body fld Pt Qn     ACTIVE Choriogonadotropin.beta subunit free [Units/volume] in Body fluid   MIN DefinitionDescription     IU/L             CHEM   47601-0         Both       0 B-HCG Free Fld-aCnc       N   Arbitrary concentration; B; B HCG; B/F; Beta HCG; Beta human chorionic gonadotropin; BF; B-HCG; B-HCG Free; bod; Bodies; Body fluid; Body fluid, unsp; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Fl; Fld; FLU; Fluid; FR; HCG; Human chorionic gonadotropin; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker 2.7 2.21               [IU]/L       0
47602-8 Citrate synthase CCnt WBC Pt Qn     ACTIVE Citrate synthase [Enzymatic activity/mass] in Leukocytes   MIN DefinitionDescription     nmol/min/mg protein             CHEM   47602-8         Both       0 Citrate Synthase WBC-cCnt       N   Catalytic Content; Chemistry; Citric acid; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.7 2.21               nmol/min/mg{protein}       0
47603-6 Citrate synthase CCnt Fibroblasts Pt Qn     ACTIVE Citrate synthase [Enzymatic activity/mass] in Fibroblast   MIN DefinitionDescription     nmol/min/mg protein             CHEM   47603-6         Both       0 Citrate Synthase Fib-cCnt       N   Catalytic Content; Chemistry; Citric acid; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random 2.7 2.21               nmol/min/mg{protein}       0
104,672 results found